Navigation Links
Neurocrine Biosciences to Present at the Citi 2012 Global Health Care Conference
Date:2/21/2012

SAN DIEGO, Feb. 21, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Citi 2012 Global Health Care Conference in New York.   

The live presentation takes place on Wednesday, February 29 at 11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time.  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, stress-related disorders, tardive dyskinesia, uterine fibroids, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
2. Neurocrine Biosciences Reports Third Quarter 2011 Results
3. Neurocrine Biosciences Reports Second Quarter 2011 Results
4. Neurocrine Biosciences Announces Notice of Allowance for Composition of Matter Patent on VMAT2 Inhibitor
5. Neurocrine Biosciences Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor
6. Neurocrine Biosciences to Present at the Cowen & Co. 31st Annual Health Care Conference
7. Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results
8. Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2010 Financial Results
9. Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the Treatment of Endometriosis
10. Neurocrine Biosciences Announces Conference Call and Webcast on Worldwide Agreement With Abbott on Elagolix
11. Neurocrine Biosciences to Present at the Jefferies 2010 Global Life Sciences Conference and the 9th Annual Needham Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2020)... ... June 23, 2020 , ... Nobilis Therapeutics, a biopharmaceutical ... has filed an Investigational New Drug application (IND) with the U.S. Food & ... drug candidate NBTX-001 in patients with panic disorder (PD). , "Adding a PD ...
(Date:6/11/2020)... (PRWEB) , ... June 08, 2020 , ... ... universal vaccine platform delivered through the use of proprietary clean viral vectors, recently ... in the United States. Greffex’s platform is the world’s most successful gene ...
(Date:6/11/2020)... ... June 09, 2020 , ... TRX Systems, developer ... Micro-Tracer Solution, a highly accurate, contact tracing solution for identification of employees ... tracing, a core disease control measure, is a key strategy for preventing further ...
(Date:6/3/2020)... ... June 03, 2020 , ... Thought Technology Ltd. ... In the next installment, Dr. Inna Khazan will discuss the benefits of using ... their attention to the feelings, thoughts, and emotions they are having in the ...
Breaking Biology Technology:
(Date:6/19/2020)... ... June 18, 2020 , ... Join experts from Envigo Lauren Klaskala, ... live webinar on Wednesday, July 8, 2020 at 11am EDT (4pm BST/UK). ... engineer new models. However, while modifying the genome may be more straightforward, the challenge ...
(Date:6/5/2020)... CULVER CITY, Calif. (PRWEB) , ... June 04, 2020 , ... ... is for the health and well-being of our attendees, staff, and the public. ... there are unique and safe ways to collaborate virtually,” said Julie Sutcliffe, President of ...
(Date:5/28/2020)... ... May 27, 2020 , ... Today bioinformatics leader hc1® ... uniquely combines lab testing insights and hc1’s exclusive Local Risk Index in a ... safety of employees returning to the workplace. , “Some of the best ways ...
Breaking Biology News(10 mins):